Examining the technical indicators, the Moving Average Convergence Divergence (MACD) presents a mixed picture: weekly data suggests a mildly bullish stance, whereas monthly readings indicate bearish momentum. The Relative Strength Index (RSI) remains neutral on both weekly and monthly scales, showing no definitive signal. Meanwhile, Bollinger Bands align with a bearish outlook across weekly and monthly periods, reinforcing the recent downward pressure on the stock price.
Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!
- Complete fundamentals package
- Technical momentum confirmed
- Reasonable valuation entry
Further technical analysis reveals that daily moving averages are bearish, consistent with the overall trend shift. The Know Sure Thing (KST) indicator supports this bearish sentiment on both weekly and monthly timeframes. Dow Theory readings offer a nuanced view, mildly bullish on a weekly basis but mildly bearish monthly, indicating short-term resilience amid longer-term caution. On-balance volume (OBV) shows no clear trend weekly but suggests mild bullishness monthly, hinting at some accumulation despite price pressures.
From a market performance perspective, Syngene International’s returns contrast sharply with the broader Sensex index. Over the past week, the stock’s return was marginally negative at -0.03%, while the Sensex gained 0.96%. Over one month, Syngene International recorded a 1.07% return, slightly ahead of the Sensex’s 0.86%. However, year-to-date and one-year returns reveal a significant divergence, with the stock showing declines of -24.86% and -23.66% respectively, compared to Sensex gains of 8.36% and 9.48%. Longer-term returns over three, five, and ten years show positive growth for Syngene International, though these lag behind the Sensex’s more robust performance, particularly over five years (12.60% versus 91.65%) and ten years (258.44% versus 232.28%).
Why settle for Syngene International ? SwitchER evaluates this Healthcare Services small-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- Comprehensive evaluation done
- Superior opportunities identified
- Smart switching enabled
These technical and performance indicators collectively suggest an adjustment in the evaluation of Syngene International’s stock momentum. The recent change in the Mojo Score to 28.0, accompanied by a revision in its grade to Strong Sell from Sell as of 18 Nov 2025, reflects this shift. The market capitalisation grade remains modest at 3, underscoring the stock’s current positioning within its sector and market context.
Investors analysing Syngene International should weigh these technical signals alongside broader market conditions and sectoral trends within Healthcare Services. The mixed signals from momentum indicators and the divergence from benchmark returns highlight the importance of a cautious and data-driven approach when considering exposure to this stock.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
